Historical Shocks, Subsidiary Autonomy, and Innovation in Global Pharmaceuticals
Abstract
How do multinational subsidiaries reinvent themselves when a sudden institutional shock rewrites the rules of innovation?
Fields of Study & Subjects
International Business and FDI
Innovation and Knowledge Management
Pharmaceutical Economics and Policy
Publication details
- Publication date
- 1 January 2026